Rosetta Genomics , Nasdaq: ROSG
An early stage developer of microRNA-based diagnostic and therapeutic products.
Industry: Health Care
First Day Return: +4.6%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 09/01/2006 |
| Offer Price | $7.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 3.8 |
| Deal Size ($mm) | $26 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/26/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $26 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Rehovot, Israel |
| Founded | 2000 |
| Employees at IPO | 41 |
| Website www.rosettagenomics.com | |
Rosetta Genomics (ROSG) Performance
